Stegent Equity Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Sell
1,013
-200
-16% -$55.3K 0.16% 104
2026
Q1
$358K Sell
1,213
-181
-13% -$53.8K 0.31% 77
2025
Q4
$381K Sell
1,394
-48
-3% -$13K 0.3% 82
2025
Q3
$390K Sell
1,442
-244
-14% -$66.4K 0.32% 81
2025
Q2
$465K Buy
1,686
+121
+8% +$32.9K 0.41% 76
2025
Q1
$415K Sell
1,565
-200
-11% -$49.3K 0.42% 72
2024
Q4
$410K Buy
1,765
+294
+20% +$67.6K 0.42% 61
2024
Q3
$325K Buy
1,471
+72
+5% +$14.9K 0.36% 66
2024
Q2
$275K Sell
1,399
-92
-6% -$19K 0.29% 71
2024
Q1
$321K Buy
+1,491
New +$313K 0.33% 64

Other funds holding CME

Stegent Equity Advisors's CME Position: Q2 2026 in Review

Stegent Equity Advisors reduced its CME Group (CME) stake by 16% in Q2 2026, selling an estimated $55.3K and leaving 1,013 shares worth $224K. The position accounts for 0.16% of the portfolio, ranked #104.

Stegent Equity Advisors first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $465K in Q2 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Stegent Equity Advisors held 1,013 shares of CME Group worth $224K as of Q2 2026.
  • Stegent Equity Advisors sold 200 CME Group shares in Q2 2026, an estimated $55.3K.
  • CME Group made up 0.16% of Stegent Equity Advisors's portfolio in Q2 2026, its #104 holding.
  • Stegent Equity Advisors first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • Stegent Equity Advisors's CME Group position peaked at $465K in Q2 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Stegent Equity Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.